Moderated Discussion: Embolic Protection for All TAVR Patients - The Pros and Cons

Monday, February 27, 2023

2:10 PM – 2:25 PM ET

Panel Moderator(s)

Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No relevant disclosure to display
Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

No relationships to disclose

Panel Discussant(s)

James E. Harvey, III, MD

VP and CMO - Heart & Vascular Service Line
WellSpan Health

Disclosure(s): Abiomed: Consultant (Ongoing); Avail: Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)
Issam Moussa, MD

Associate Dean for Research and Innovation
Carle Illinois College of Medicine / University of Illinois Urbana Champaign
Beverly Hills, California, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisory Committee/Board Member (Ongoing); Emboline, Inc.: Board Member (Ongoing)
Zach Rozenbaum, MD

Assistant Professor
Tulane University, Louisiana, United States

No relationships to disclose
Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)
Giora Weisz, MD (he/him/his)

interventional Cardiology
NewYork Presbyterian Hospital - Columbia University Medical Center
New York, New York, United States

Disclosure(s): Filterlex: Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing); Intratech: Officer or Board Member (Ongoing); Microbot: Advisory Committee/Board Member (Ongoing)

Disclosure(s):

Samir R. Kapadia, MD, FSCAI: No relevant disclosure to display

James E. Harvey, MD, III: Abiomed: Consultant (Ongoing); Avail: Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

Issam Moussa, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisory Committee/Board Member (Ongoing); Emboline, Inc.: Board Member (Ongoing)

Nicolas M. Van Mieghem, MD, PhD, FESC, FACC: Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

Giora Weisz, MD: Filterlex: Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing); Intratech: Officer or Board Member (Ongoing); Microbot: Advisory Committee/Board Member (Ongoing)